Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Ultralife

DB:ULB
Snowflake Description

Adequate balance sheet and fair value.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
ULB
DB
$84M
Market Cap
  1. Home
  2. DE
  3. Capital Goods
Company description

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The last earnings update was 54 days ago. More info.


Add to Portfolio Compare Print
  • Ultralife has significant price volatility in the past 3 months.
ULB Share Price and Events
7 Day Returns
-2.6%
DB:ULB
9.2%
DE Electrical
9.9%
DE Market
1 Year Returns
-49.4%
DB:ULB
-8.2%
DE Electrical
-17.5%
DE Market
ULB Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Ultralife (ULB) -2.6% -21.4% -28.8% -49.4% -6.5% 29%
DE Electrical 9.2% -20.6% -35.2% -8.2% -43.7% -44.1%
DE Market 9.9% -16.6% -24.8% -17.5% -24.5% -28.1%
1 Year Return vs Industry and Market
  • ULB underperformed the Electrical industry which returned -8.2% over the past year.
  • ULB underperformed the Market in Germany which returned -17.5% over the past year.
Price Volatility
ULB
Industry
5yr Volatility vs Market

Value

 Is Ultralife undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
  • It is not possible to calculate the future cash flow value for Ultralife. This is due to cash flow or dividend data being unavailable. The share price is €4.56.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Ultralife's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Ultralife's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
DB:ULB PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $0.33
NasdaqGM:ULBI Share Price ** NasdaqGM (2020-03-31) in USD $5.29
Germany Electrical Industry PE Ratio Median Figure of 6 Publicly-Listed Electrical Companies 22.57x
Germany Market PE Ratio Median Figure of 399 Publicly-Listed Companies 16.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Ultralife.

DB:ULB PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGM:ULBI Share Price ÷ EPS (both in USD)

= 5.29 ÷ 0.33

16.04x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ultralife is good value based on earnings compared to the DE Electrical industry average.
  • Ultralife is good value based on earnings compared to the Germany market.
Price based on expected Growth
Does Ultralife's expected growth come at a high price?
Raw Data
DB:ULB PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 16.04x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 0 Analysts
Not available
Germany Electrical Industry PEG Ratio Median Figure of 5 Publicly-Listed Electrical Companies 1x
Germany Market PEG Ratio Median Figure of 255 Publicly-Listed Companies 1.18x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Ultralife, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Ultralife's assets?
Raw Data
DB:ULB PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $6.92
NasdaqGM:ULBI Share Price * NasdaqGM (2020-03-31) in USD $5.29
Germany Electrical Industry PB Ratio Median Figure of 14 Publicly-Listed Electrical Companies 1.69x
Germany Market PB Ratio Median Figure of 571 Publicly-Listed Companies 1.43x
DB:ULB PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGM:ULBI Share Price ÷ Book Value per Share (both in USD)

= 5.29 ÷ 6.92

0.76x

* Primary Listing of Ultralife.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Ultralife is good value based on assets compared to the DE Electrical industry average.
X
Value checks
We assess Ultralife's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Electrical industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Electrical industry average (and greater than 0)? (1 check)
  5. Ultralife has a total score of 3/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

Future Performance

 How is Ultralife expected to perform in the next 1 to 3 years based on estimates from 0 analysts?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Ultralife has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.

Show me the analysis anyway

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
69.2%
Expected Electrical industry annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Ultralife expected to grow at an attractive rate?
  • Unable to compare Ultralife's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
  • Unable to compare Ultralife's earnings growth to the Germany market average as no estimate data is available.
  • Unable to compare Ultralife's revenue growth to the Germany market average as no estimate data is available.
Annual Growth Rates Comparison
Raw Data
DB:ULB Future Growth Rates Data Sources
Data Point Source Value (per year)
Germany Electrical Industry Earnings Growth Rate Market Cap Weighted Average 69.2%
Germany Electrical Industry Revenue Growth Rate Market Cap Weighted Average 12.4%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.4%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
DB:ULB Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
DB:ULB Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 107 -3 5
2019-09-29 97 -1 23
2019-06-30 90 5 24
2019-03-31 83 11 23
2018-12-31 87 11 25
2018-09-30 89 11 9
2018-07-01 89 5 9
2018-04-01 87 4 8
2017-12-31 86 7 8
2017-10-01 85 8 6
2017-07-02 83 12 6
2017-04-02 84 13 5

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Unable to determine if Ultralife is high growth as no earnings estimate data is available.
  • Unable to determine if Ultralife is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
DB:ULB Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below

All data from Ultralife Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:ULB Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 0.33
2019-09-29 1.48
2019-06-30 1.50
2019-03-31 1.46
2018-12-31 1.57
2018-09-30 0.57
2018-07-01 0.55
2018-04-01 0.52
2017-12-31 0.49
2017-10-01 0.36
2017-07-02 0.36
2017-04-02 0.32

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Unable to establish if Ultralife will efficiently use shareholders’ funds in the future without estimates of Return on Equity.

Next steps:

  1. Examine whether Ultralife is trading at Ultralife'san attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  2. Ultralife's future outlook can be gauged by looking at industry trends and market size, and determining how well-positioned the company is compared to its competitors. Take a look at other high-growth Capital Goods companies here
  3. Ultralife's competitive advantages and company strategy can generally be found in its financial reports archived here.
  4. Use fundamentals to screen for another stock to analyse from our database of over 75,000 companies worldwide
X
Future performance checks
We assess Ultralife's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Ultralife has a total score of 0/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

Past Performance

  How has Ultralife performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Ultralife's growth in the last year to its industry (Electrical).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Ultralife has delivered over 20% year on year earnings growth in the past 5 years.
  • Ultralife's 1-year earnings growth is negative, it can't be compared to the 5-year average.
  • Ultralife's 1-year earnings growth is negative, it can't be compared to the DE Electrical industry average.
Earnings and Revenue History
Ultralife's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Ultralife Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

DB:ULB Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 106.80 5.21 16.99 6.81
2019-09-29 96.70 23.32 15.65 5.74
2019-06-30 89.54 23.83 14.73 4.81
2019-03-31 83.00 23.20 14.20 4.44
2018-12-31 87.19 24.93 14.52 4.51
2018-09-30 88.77 8.99 14.73 4.48
2018-07-01 89.49 8.68 14.92 4.73
2018-04-01 86.57 8.14 14.93 4.70
2017-12-31 85.53 7.65 15.02 4.74
2017-10-01 84.65 5.59 14.92 5.19
2017-07-02 83.23 5.51 14.78 5.19
2017-04-02 83.66 4.87 15.04 5.43
2016-12-31 82.46 3.51 15.20 5.95
2016-09-25 80.09 2.27 14.74 6.12
2016-06-26 79.50 2.29 14.74 5.99
2016-03-27 78.08 2.64 14.47 5.90
2015-12-31 76.43 2.87 14.23 5.60
2015-09-27 77.12 3.22 15.00 5.08
2015-06-28 74.14 1.85 15.02 4.87
2015-03-29 70.39 -0.30 15.29 5.10
2014-12-31 66.49 -2.06 15.46 5.17
2014-09-28 66.72 -2.81 15.47 5.41
2014-06-29 71.02 -1.86 16.00 5.82
2014-03-30 73.10 -2.45 16.75 5.93
2013-12-31 78.84 -1.05 17.39 5.86
2013-09-29 87.93 0.92 19.01 5.97
2013-06-30 93.75 1.77 19.82 6.15

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Ultralife has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Ultralife used its assets less efficiently than the DE Electrical industry average last year based on Return on Assets.
  • Ultralife has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Ultralife's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Electrical industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Ultralife has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

Health

 How is Ultralife's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Ultralife's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Ultralife is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Ultralife's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Ultralife's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 4.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Ultralife Company Filings, last reported 3 months ago.

DB:ULB Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 109.75 17.15 7.41
2019-09-29 106.85 17.58 7.09
2019-06-30 106.05 15.78 6.82
2019-03-31 103.92 0.00 21.24
2018-12-31 104.46 0.00 25.93
2018-09-30 85.50 0.00 25.01
2018-07-01 84.07 0.00 20.29
2018-04-01 83.09 0.00 18.24
2017-12-31 79.05 0.00 18.24
2017-10-01 74.54 0.00 14.61
2017-07-02 72.75 0.00 14.93
2017-04-02 70.57 0.00 13.60
2016-12-31 67.86 0.00 10.63
2016-09-25 66.55 0.00 6.65
2016-06-26 65.86 0.83 3.12
2016-03-27 66.21 1.16 2.76
2015-12-31 66.02 0.00 14.39
2015-09-27 65.18 0.00 14.59
2015-06-28 67.70 0.00 15.79
2015-03-29 72.27 0.00 20.13
2014-12-31 71.91 0.00 17.71
2014-09-28 71.01 0.00 15.57
2014-06-29 71.62 0.00 17.16
2014-03-30 72.66 0.00 18.90
2013-12-31 73.65 0.00 16.07
2013-09-29 73.24 0.00 10.37
2013-06-30 72.27 0.00 11.16
  • Ultralife's level of debt (15.6%) compared to net worth is satisfactory (less than 40%).
  • Unable to establish if Ultralife's debt level has increased without past 5-year debt data.
  • Operating cash flow is negative therefore debt is not well covered.
  • Interest payments on debt are well covered by earnings (EBIT is 20x coverage).
X
Financial health checks
We assess Ultralife's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Ultralife has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

Dividends

 What is Ultralife's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Ultralife dividends.
If you bought €2,000 of Ultralife shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Ultralife's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Ultralife's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
DB:ULB Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 0 Analyst Estimates (S&P Global) See Below
Germany Electrical Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 2%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.8%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Ultralife has not reported any payouts.
  • Unable to verify if Ultralife's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Ultralife's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Ultralife has not reported any payouts.
Future Payout to shareholders
  • Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.
X
Income/ dividend checks
We assess Ultralife's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Ultralife afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Ultralife has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

Management

 What is the CEO of Ultralife's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Mike Popielec
COMPENSATION $955,717
AGE 57
TENURE AS CEO 9.3 years
CEO Bio

Mr. Michael D. Popielec, also known as Mike, has been the President and Chief Executive Officer of Ultralife Corporation since December 30, 2010. Mr. Popielec served as the Group President of Applied Technologies of Carlisle Companies Inc. from September 2005 to July 2009. He served as the Group President of Diversified Components of Carlisle Companies Inc. since September 2005 and was responsible for the operations of Carlisle Braking Systems, Carlisle FoodService, Tensolite, Trail King Industries, the Walker Group and Johnson Truck Bodies. He served as the Chief Operating Officer of Americas of Danka Business Systems PLC from April 1, 2004 to April 2005. He served as the Chief Operating Officer of Danka International at Danka Business Systems PLC. since April 8, 2003 and served as its President. From 1985 to April 2003, Mr. Popielec served in a variety of roles with General Electric Company for 8 years, as President and Chief Executive Officer of GE Power Controls, Industrial Systems from 2000 to 2003. Mr. Popielec has been a Director of Ultralife Corporation since December 30, 2010. Mr. Popielec has a B.S. in Mechanical Engineering from Michigan State University.

CEO Compensation
  • Mike's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Mike's remuneration is higher than average for companies of similar size in Germany.
Management Team Tenure

Average tenure of the Ultralife management team in years:

9.3
Average Tenure
  • The average tenure for the Ultralife management team is over 5 years, this suggests they are a seasoned and experienced team.
Management Team

Mike Popielec

TITLE
CEO, President & Director
COMPENSATION
$956K
AGE
57
TENURE
9.3 yrs

Phil Fain

TITLE
CFO, Treasurer & Corporate Secretary
COMPENSATION
$453K
AGE
64
TENURE
10.3 yrs

James J. Rasmussen

TITLE
President of Communication System

Michael Manna

TITLE
President of Battery & Energy Products
TENURE
0.4 yrs
Board of Directors Tenure

Average tenure and age of the Ultralife board of directors in years:

10
Average Tenure
62
Average Age
  • The average tenure for the Ultralife board of directors is over 10 years, this suggests they are a seasoned and experienced board.
Board of Directors

Bradford Whitmore

TITLE
Independent Chairman
COMPENSATION
$98K
AGE
61
TENURE
10 yrs

Mike Popielec

TITLE
CEO, President & Director
COMPENSATION
$956K
AGE
57
TENURE
9.3 yrs

Raj Singh

TITLE
Independent Director
COMPENSATION
$90K
AGE
66
TENURE
19.6 yrs

Tom Saeli

TITLE
Independent Director
COMPENSATION
$89K
AGE
62
TENURE
10 yrs

Bob Shaw

TITLE
Independent Director
COMPENSATION
$87K
AGE
62
TENURE
9.7 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Ultralife individual insiders in the past 3 months, but not in substantial volumes.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
17. Mar 20 Buy Grace Brothers Management, LLC Company 13. Mar 20 17. Mar 20 50,000 €5.64 €250,442
28. Feb 20 Buy Philip Fain Individual 26. Feb 20 27. Feb 20 2,771 €6.65 €18,399
20. Feb 20 Buy Grace Brothers Management, LLC Company 18. Feb 20 19. Feb 20 100,000 €6.81 €670,383
13. May 19 Buy Robert Shaw Individual 13. May 19 13. May 19 1,500 €7.46 €11,191
X
Management checks
We assess Ultralife's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Ultralife has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

News

Simply Wall St News

Company Info

Description

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company serves government, defense, and commercial sectors. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables. The Communications Systems segment provides communications systems and accessories to support military communications systems, such as radio frequency amplifiers, power supplies and cables, connector assemblies, amplified speakers, equipment mounts, case equipment, man-portable systems, and integrated communication systems for fixed or vehicle applications comprising vehicle adapters, vehicle installed power enhanced rifleman appliqué systems, and SATCOM systems. This segment’s military communications systems and accessories are designed to enhance and extend the operation of communications equipment, such as vehicle-mounted, manpack, and handheld transceivers. It sells its products under the Ultralife, Lithium Power, McDowell Research, AMTI, ABLE, ACCUTRONICS, ACCUPRO, ENTELLION, SWE DRILL-DATA, and SWE SEASAFE brands through original equipment manufacturers, and industrial and defense supply distributors, as well as directly to the United States and international defense departments. In addition, the company sells its 9-volt battery to the broader consumer market through national and regional retail chains and Internet retailers. Ultralife Corporation was founded in 1990 and is headquartered in Newark, New York.

Details
Name: Ultralife Corporation
ULB
Exchange: DB
Founded: 1990
$76,399,904
15,870,688
Website: http://www.ultralifecorporation.com
Address: Ultralife Corporation
2000 Technology Parkway,
Newark,
New York, 14513,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGM ULBI Common Stock Nasdaq Global Market US USD 23. Dec 1992
DB ULB Common Stock Deutsche Boerse AG DE EUR 23. Dec 1992
Number of employees
Current staff
Staff numbers
573
Ultralife employees.
Industry
Electrical Components and Equipment
Capital Goods
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 20:39
End of day share price update: 2020/03/31 00:00
Last earnings filing: 2020/02/06
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.